<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font6" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font8" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font9" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font11" size="7" family="GillSans" color="#000000"/>
<text top="41" left="55" width="122" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Medical Immunology 2006, 5 :1<i>Medical Immunology</i></text>
<text top="41" left="384" width="170" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.medimmunol.com/content/5/1/1</text>
<text top="756" left="498" width="56" height="10" font="font1" id="p1_t3" reading_order_no="75" segment_no="11" tag_type="text">Page 10 of 14<b>5</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="76" segment_no="12" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="text">specific T cell line after several stimulations in vitro (Fig.</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="text">2E, first plot) and their peptide specificities determined by</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="text">individual peptide-loaded DimerX staining (Figure 2E).<i>(page number not for citation purposes)</i></text>
<text top="121" left="55" width="241" height="10" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">One to nine percent of CD8 + T cells were specific for each</text>
<text top="134" left="55" width="202" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">one of the selected HIV-1B peptides (Figure 2F).<i>in vitro </i></text>
<text top="157" left="55" width="239" height="9" font="font7" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="title">Cytotoxic activity of HIV-1 peptide-specific CD8+ T cells</text>
<text top="169" left="55" width="135" height="9" font="font7" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="title">derived from HIV-1 naive donors<a href="">2E, first</a> plot) and their peptide specificities determined by</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="5" tag_type="text">Next, to test for potential cytolytic activity of the HIV-1<a href="">2E).</a></text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="5" tag_type="text">peptide-specific T cell lines, T2 hybridoma cells were</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="5" tag_type="text">pulsed with A0201 restricted HIV-1B peptide pools and</text>
<text top="215" left="55" width="241" height="10" font="font4" id="p1_t15" reading_order_no="12" segment_no="5" tag_type="text">specific lysis was determined by standard 51 Cr release</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="5" tag_type="text">assay. As shown in Figure 3A, the HIV-1 peptide-specific<a href="">igure 2F</a>).</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="5" tag_type="text">CD8 + T cells killed A0201 restricted HIV-1 peptide pool-<i><b>Cytotoxic activity of HIV-1 peptide-specific CD8+ T cells </b></i></text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="5" tag_type="text">pulsed T2 cells with ~50% specific lysis at an E:T ratio of<i><b>derived from HIV-1 naive donors</b></i></text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="5" tag_type="text">30:1. The same T2 cells loaded with HTLV-TAX peptide as</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="5" tag_type="text">a negative control were not lysed. To determine whether</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="5" tag_type="text">HIV-1 peptide-specific A0201 restricted CTL can recognize</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t22" reading_order_no="33" segment_no="3" tag_type="text">and lyse HIV-1 -infected cells, we infected the T1 hybrid-</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t23" reading_order_no="34" segment_no="3" tag_type="text">oma line (A0201+, B5101 + , CD4 + ) with HIV-IIIB virus</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t24" reading_order_no="35" segment_no="3" tag_type="text">and then determined whether HIV-1 peptide specific</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t25" reading_order_no="36" segment_no="3" tag_type="text">A0201 restricted CTL can recognize HIV-IIIB infected T1<a href="">in Figure 3A, th</a>e HIV-1 peptide-specific</text>
<text top="133" left="313" width="241" height="10" font="font4" id="p1_t26" reading_order_no="37" segment_no="3" tag_type="text">cells and kill target cells in a 51 Cr release assay. HIV-1 spe-</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t27" reading_order_no="38" segment_no="3" tag_type="text">cific CD8 T cells from two different A0201 donors recog-</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t28" reading_order_no="39" segment_no="3" tag_type="text">nized and killed 20–28% of HIV-1 infected T1 cells 2 and</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t29" reading_order_no="40" segment_no="3" tag_type="text">3 days after infection at an E:T ratio of 30:1 while unin-</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t30" reading_order_no="41" segment_no="3" tag_type="text">fected T1 cells were not lysed (Figures 3B and 3C). We also</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t31" reading_order_no="42" segment_no="3" tag_type="text">noted that although some of these peptides (for example,</text>
<text top="204" left="313" width="242" height="9" font="font4" id="p1_t32" reading_order_no="43" segment_no="3" tag_type="text">TLNAWYKVI) bind to related alleles, CD8 + T cells stimu-</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="44" segment_no="3" tag_type="text">lated from the A0201* donor fail to specifically lyse pep-</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t34" reading_order_no="45" segment_no="3" tag_type="text">tide-pulsed A0202, A0203 or A0204 targets (Figure 4).</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t35" reading_order_no="46" segment_no="3" tag_type="text">Thus, a given CTL response is less degenerate than peptide</text>
<text top="251" left="313" width="72" height="9" font="font4" id="p1_t36" reading_order_no="47" segment_no="3" tag_type="text">binding to MHC.</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t37" reading_order_no="48" segment_no="6" tag_type="text">As shown in Figure 4, A0201 restricted HIV-1-specific CTL</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t38" reading_order_no="49" segment_no="6" tag_type="text">demonstrate alloreactivity and kill A0202, A0203 and</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="50" segment_no="6" tag_type="text">A0204 transfected 721–221 targets in the absence of HIV-</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t40" reading_order_no="51" segment_no="6" tag_type="text">1 peptide loading. Moreover, in the presence of HIV-1</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t41" reading_order_no="52" segment_no="6" tag_type="text">peptides, alloreactivity against A0202, A0203 and A0204</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="53" segment_no="6" tag_type="text">transfected 721–221 targets decrease as shown by dimin-</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t43" reading_order_no="54" segment_no="6" tag_type="text">ished lysis. These results suggest that A0201 restricted</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="55" segment_no="6" tag_type="text">HIV-1 peptides bind to A0202, A0203 and A0204, replac-</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="56" segment_no="6" tag_type="text">ing possible endogenous peptides that mediate much of</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="57" segment_no="6" tag_type="text">the evident alloreactivity. The analysis of the A0204 trans-</text>
<text top="392" left="313" width="197" height="9" font="font4" id="p1_t47" reading_order_no="58" segment_no="6" tag_type="text">fectant is a clear example of this phenomenon.<a href="">igures 3</a>B an<a href="">d 3C). We als</a>o</text>
<text top="570" left="313" width="227" height="9" font="font8" id="p1_t48" reading_order_no="61" segment_no="7" tag_type="title">Allele-restricted fine specificity of CTL directed at HIV-1</text>
<text top="570" left="313" width="33" height="9" font="font8" id="p1_t49" reading_order_no="59" segment_no="7" tag_type="title">peptides</text>
<text top="570" left="313" width="37" height="9" font="font9" id="p1_t50" reading_order_no="60" segment_no="7" tag_type="title">Figure 4</text>
<text top="580" left="313" width="231" height="9" font="font9" id="p1_t51" reading_order_no="62" segment_no="8" tag_type="text">Allele-restricted fine specificity of CTL directed at</text>
<text top="591" left="313" width="239" height="9" font="font9" id="p1_t52" reading_order_no="63" segment_no="8" tag_type="text">HIV-1 peptides . HIV-1 peptide-specific T cells were gener-</text>
<text top="602" left="313" width="241" height="9" font="font10" id="p1_t53" reading_order_no="64" segment_no="8" tag_type="text">ated from an A0201 donor using predicted A0201-restricted<a href="">igure 4).</a></text>
<text top="613" left="313" width="241" height="9" font="font10" id="p1_t54" reading_order_no="65" segment_no="8" tag_type="text">HIV-1 peptides (Table 1 and Fig. 1). HIV-1 peptide-specific T</text>
<text top="623" left="313" width="237" height="9" font="font10" id="p1_t55" reading_order_no="66" segment_no="8" tag_type="text">cells killed the A0201 transfected 721–221 cell line in a pep-</text>
<text top="634" left="313" width="236" height="9" font="font10" id="p1_t56" reading_order_no="67" segment_no="8" tag_type="text">tide-specific manner by 51 Cr release assay. To test possible<a href=""> 4, A020</a>1 restricted HIV-1-specific CTL</text>
<text top="645" left="313" width="233" height="9" font="font10" id="p1_t57" reading_order_no="68" segment_no="8" tag_type="text">cross-reactivity of A0201 restricted HIV-1 peptide-specific</text>
<text top="656" left="313" width="225" height="9" font="font10" id="p1_t58" reading_order_no="69" segment_no="8" tag_type="text">CTL to other A02 alleles, we utilized A0202, A0203 and</text>
<text top="666" left="313" width="241" height="9" font="font10" id="p1_t59" reading_order_no="70" segment_no="8" tag_type="text">A0204 transfected 721–221 cells as targets. A0201 restricted</text>
<text top="677" left="313" width="224" height="9" font="font10" id="p1_t60" reading_order_no="71" segment_no="8" tag_type="text">HIV-1 peptide specific CTLs killed HIV-1 peptide loaded</text>
<text top="688" left="313" width="240" height="9" font="font10" id="p1_t61" reading_order_no="72" segment_no="8" tag_type="text">A0201 transfected 721–221 targets at a 10:1 ratio.  +pp indi-</text>
<text top="699" left="313" width="229" height="9" font="font10" id="p1_t62" reading_order_no="73" segment_no="8" tag_type="text">cates addition of peptide pool, with solid bar = lysis upon</text>
<text top="709" left="313" width="216" height="9" font="font10" id="p1_t63" reading_order_no="74" segment_no="8" tag_type="text">+pp and gray bar = lysis with no peptide pool addition.</text>
<text top="589" left="55" width="241" height="9" font="font8" id="p1_t64" reading_order_no="21" segment_no="9" tag_type="title">Cytotoxic activity of HIV-1 peptide-specific A0201 restricted</text>
<text top="589" left="55" width="109" height="9" font="font8" id="p1_t65" reading_order_no="20" segment_no="9" tag_type="title">T cells from normal donors</text>
<text top="589" left="55" width="37" height="9" font="font9" id="p1_t66" reading_order_no="19" segment_no="9" tag_type="title">Figure 3</text>
<text top="600" left="55" width="230" height="9" font="font9" id="p1_t67" reading_order_no="22" segment_no="10" tag_type="text">Cytotoxic activity of HIV-1 peptide-specific A0201</text>
<text top="610" left="55" width="237" height="9" font="font9" id="p1_t68" reading_order_no="23" segment_no="10" tag_type="text">restricted T cells from normal donors . CTL were gen-</text>
<text top="621" left="55" width="231" height="9" font="font10" id="p1_t69" reading_order_no="24" segment_no="10" tag_type="text">erated against a pool of eight A0201 restricted HIV-1 pep-<b>Figure 4</b></text>
<text top="632" left="55" width="232" height="9" font="font10" id="p1_t70" reading_order_no="25" segment_no="10" tag_type="text">tides using PBMC. HIV-1 specific CTL lysed HIV-1 peptide<b>Allele-restricted fine specificity of CTL directed at </b></text>
<text top="643" left="55" width="241" height="9" font="font10" id="p1_t71" reading_order_no="26" segment_no="10" tag_type="text">loaded T2 cells (solid symbols) but not the irrelevant peptide<b>HIV-1 peptides</b></text>
<text top="653" left="55" width="235" height="9" font="font10" id="p1_t72" reading_order_no="27" segment_no="10" tag_type="text">loaded T2 cells (open symbols) in 51 Cr release assay (Panel</text>
<text top="664" left="55" width="222" height="9" font="font10" id="p1_t73" reading_order_no="28" segment_no="10" tag_type="text">A). HIV-1 specific CTL generated from 2 different naïve</text>
<text top="675" left="55" width="235" height="9" font="font10" id="p1_t74" reading_order_no="29" segment_no="10" tag_type="text">donors lysed HIV-IIIB- infected T1 cells (solid symbols) but</text>
<text top="686" left="55" width="229" height="9" font="font10" id="p1_t75" reading_order_no="30" segment_no="10" tag_type="text">not uninfected T1 cells (open symbols) 2 and 3 days after</text>
<text top="696" left="55" width="220" height="9" font="font10" id="p1_t76" reading_order_no="31" segment_no="10" tag_type="text">acute infection, in a 51 Cr release assay (Panels B and C,</text>
<text top="707" left="55" width="52" height="9" font="font10" id="p1_t77" reading_order_no="32" segment_no="10" tag_type="text">respectively).</text>
</page>
</pdf2xml>
